T

Trulieve Cannabis Corp
CNSX:TRUL

Watchlist Manager
Trulieve Cannabis Corp
CNSX:TRUL
Watchlist
Price: 15.31 CAD 5.59% Market Closed
Market Cap: 2.9B CAD

Relative Value

The Relative Value of one TRUL stock under the Base Case scenario is hidden CAD. Compared to the current market price of 15.31 CAD, Trulieve Cannabis Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TRUL Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
41
vs Industry
79
Median 3Y
0.9
Median 5Y
1.5
Industry
2.6
Forward
1.7
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-4.1
Industry
21.6
Forward
-26.7
vs History
38
vs Industry
52
Median 3Y
4.9
Median 5Y
6.1
Industry
16.5
vs History
6
vs Industry
35
Median 3Y
-1.2
Median 5Y
-4.9
Industry
22.5
vs History
25
vs Industry
71
Median 3Y
0.7
Median 5Y
1.1
Industry
2.3
vs History
49
vs Industry
72
Median 3Y
1.3
Median 5Y
1.9
Industry
2.9
Forward
1.8
vs History
49
vs Industry
74
Median 3Y
2.4
Median 5Y
3.1
Industry
5.5
vs History
44
vs Industry
48
Median 3Y
5.6
Median 5Y
6.8
Industry
13
Forward
5.2
vs History
25
vs Industry
39
Median 3Y
15
Median 5Y
14.9
Industry
16.6
Forward
12.4
vs History
44
vs Industry
51
Median 3Y
6.6
Median 5Y
7.3
Industry
15.8
vs History
14
vs Industry
38
Median 3Y
10
Median 5Y
-7.6
Industry
19.1
vs History
34
vs Industry
75
Median 3Y
0.6
Median 5Y
0.8
Industry
1.9

Multiples Across Competitors

TRUL Competitors Multiples
Trulieve Cannabis Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Trulieve Cannabis Corp
CNSX:TRUL
2.8B CAD 1.8 -15.9 7.4 17.3
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.8 54.3 36.5 39.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
504B USD 5.5 20.1 16.4 21.3
CH
Roche Holding AG
SIX:ROG
252.4B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
210.7B GBP 4.8 30 108 158
CH
Novartis AG
SIX:NOVN
206.8B CHF 4.6 18.1 11.5 14.8
US
Merck & Co Inc
NYSE:MRK
245.9B USD 3.8 12.9 9.2 10.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.3 13.1 9.2 10.7
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
143B USD 2.3 14.6 7.4 10.1
P/E Multiple
Earnings Growth PEG
US
T
Trulieve Cannabis Corp
CNSX:TRUL
Average P/E: 23.7
Negative Multiple: -15.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.3
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.1
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30
38%
0.8
CH
Novartis AG
SIX:NOVN
18.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
12.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.1
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
T
Trulieve Cannabis Corp
CNSX:TRUL
Average EV/EBITDA: 399.5
7.4
11%
0.7
US
Eli Lilly and Co
NYSE:LLY
36.5
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.2
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.2
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
T
Trulieve Cannabis Corp
CNSX:TRUL
Average EV/EBIT: 1 711.7
17.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.1
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.3
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.9
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.7
1%
10.7
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
8%
1.3